Lactated Ringers
Product Images NDC 0338-9600

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Lactated Ringers (NDC 0338-9600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dhcp Letter 1 Of 17 (Image 01)

A text document titled Important Prescribing Information from Baxter Healthcare Company dated November 6, 2024. It addresses temporary importation of several injectable products including Lactated Ringer's Injection from Alliston, Canada due to drug shortages, specifying product sizes and emphasizing FDA has not approved these imported products. The letter is directed to healthcare professionals and mentions coordination with the FDA for temporary importation.*

FDA Label Image

Dhcp Letter 2 Of 17 (Image 02)

A table listing imported Baxter Healthcare Company products including 0.9% Sodium Chloride Injection, USP; 5% Dextrose Injection, USP; Lactated Ringer's Injection, USP; and Plasma-Lyte A Injection, USP. The table details sizes (250 mL to 1,000 mL), product codes, bags per carton, and NDC codes for single bags during a temporary period.*

FDA Label Image

Dhcp Letter 3 Of 17 (Image 03)

Text panel emphasizing important notes about imported products of Lactated Ringers and other injections. It discusses barcode differences, prescription availability, product compatibility, instructions for use, and key differences in labeling between FDA-approved and imported products summarized in several comparison tables.*

FDA Label Image

Dhcp Letter 4 Of 17 (Image 04)

Text panel titled 'Reporting Adverse Events or Product Quality Issues' providing instructions for reporting adverse events and product quality problems related to imported products, including contact phone numbers, fax, online reporting links, and product feedback portal details. It references FDA-approved prescribing information links for 5% Dextrose Injection, 0.9% Sodium Chloride Injection, and Lactated Ringers Injection.*

FDA Label Image

Dhcp Letter 5 Of 17 (Image 05)

Text from a letter or document referencing Plasma-Lyte Injection, USP, with contact information for Baxter's Medical Information Service and Center for Service. The letter is signed by Lee Ann Schuette, VP Global and US Marketing IV solutions at Baxter Healthcare Corporation, mentioning trademarks and attachments related to product comparison tables.*

FDA Label Image

Dhcp Letter 6 Of 17 (Image 06)

A product comparison table detailing key differences between FDA-approved and imported 0.9% Sodium Chloride Injection USP. It compares product names, label volumes, label languages, indications, active ingredients, additional information, storage conditions, container types, and medication port closures with supporting images of the medication ports.*

FDA Label Image

Dhcp Letter 7 Of 17 (Image 07)

This image shows a comparison table of label images for FDA-approved and imported 0.9% Sodium Chloride Injection USP products. It includes representative labels for a 1000 mL solution from the US FDA-approved product and the imported product from Alliston, Canada, both with black text on a white background. The table details visible label elements such as product name, volume, and manufacturer (Baxter Healthcare Corporation for US and Baxter Corporation for Canada).*

FDA Label Image

Dhcp Letter 8 Of 17 (Image 08)

A comparative data table detailing key differences between FDA-approved and imported 5% Dextrose Injection USP products. The table compares product name, label volumes, label languages, indications, active ingredients, pH and osmolarity, caloric content, storage conditions, container type, and features of medication and administration port closures. The imported product also includes French labeling.*

FDA Label Image

Dhcp Letter 9 Of 17 (Image 09)

A data table titled 'Table 4' comparing label images of FDA-approved and imported 5% Dextrose Injection USP products. It shows label colors as black for 1000 mL representative labels from US-FDA approved and imported Canadian products. Barcodes and expiration details are noted as not shown.*

FDA Label Image

Dhcp Letter 10 Of 17 (Image 10)

Label for 5% Dextrose Injection USP, 1000 mL vial, manufactured by Baxter Healthcare Company. The label displays concentration (5% Dextrose), volume (1000 mL), pH 4.0, osmolarity 252 mOsmol/L, and includes usage instructions and safety cautions in English and French. The packaging is from Baxter, with vial and closure details noted.*

FDA Label Image

Dhcp Letter 11 Of 17 (Image 11)

A data table titled 'Key differences between FDA-approved and imported Lactated Ringer's Injection, USP.' The table appears to compare various characteristics or attributes between these products. It is part of a multi-page document and includes page numbering at the bottom.*

FDA Label Image

Dhcp Letter 12 Of 17 (Image 12)

Comparison table of Lactated Ringer's Injection, USP products approved by the US FDA and imported from Alliston, Canada. The table details product name, label volumes, label languages, indications, active ingredient amounts per 100 mL, additional information, caloric content, storage conditions, container type as VIAFLEX (PVC), and medication and administration port closures featuring pull-off port protectors (blue color) on the right side.*

FDA Label Image

Dhcp Letter 13 Of 17 (Image 13)

Label images for FDA-approved and imported Lactated Ringer’s Injection USP 1000 mL from Baxter Healthcare Company. The labels are in black text, showing product name, volume, and detailed content information for intravenous fluid. One label represents the US FDA-approved product, and the other represents the imported product from Alliston, Canada, each with manufacturer and packaging details.*

FDA Label Image

Dhcp Letter 14 Of 17 (Image 14)

FDA Label Image

Dhcp Letter 15 Of 17 (Image 15)

A comparison table detailing two versions of Plasma-Lyte A Injection, USP, including a US FDA approved product and an imported product from Alliston, Canada. It includes information about product names, label volumes, language of labels, indications, active ingredient concentrations per 100 mL, additional information on pH and osmolarity, caloric content, storage conditions, and container types, highlighting differences in label volume, language, and storage temperature requirements.*

FDA Label Image

Dhcp Letter 16 Of 17 (Image 16)

Illustration showing administration port closures on an intravenous fluid bag for Lactated Ringers by Baxter Healthcare Company. The diagram highlights medication and administration ports with blue port protectors on the right side, indicating where to pull off the port protector.*

FDA Label Image

Dhcp Letter 17 Of 17 (Image 17)

A data table comparing label images of FDA-approved and imported Plasma-Lyte A Injection, USP. The table shows label details including product name, pH, electrolyte content, volume (1000 mL), and manufacturer information for both US and Canadian versions. The table highlights differences in label color, barcode presence, language, and regulatory details for each product variant.*

FDA Label Image

Container Label Ndc 0338-9600-01 (Image 18)

Label of Lactated Ringer's Injection USP by Baxter Healthcare Company, in a 1000 mL volume. The label provides chemical concentrations, storage instructions, and cautions. It includes text in both English and French, lists key electrolytes per 100 mL, and notes the product is nonpyrogenic, sterile, and apyrogenic. The label displays the Baxter logo and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.